We maintain our BUY call on Hong Leong Financial Group (HLFG) with a higher fair value of RM20.80/share (previously: RM19.40/share) based on an increase in our SOP valuation. We raised our net profit estimates for FY18/19 by 4.0%/0.6% after imputing a higher share of profit estimate from HLBB's associate, Bank of Chengdu (BOC).
HLFG reported a net profit of RM495mil in 2QFY18 (+8.8%YoY), underpinned by a higher contribution from all divisions, commercial banking, insurance and investment banking. 6MFY18 earnings of RM951mil (+14.6%YoY) were within expectations, making up 53.9% of our and 55.5% of consensus estimates.
HLFG's 64.4%-owned subsidiary, Hong Leong Bank (HLBB), reported a higher PBT of RM1.78bil (+9.0%YoY), underpinned by higher net income with an improved NIM as well as a stronger contribution of profit from its associate in China, BOC, although partially offset by higher OPEX and provisions.
HLBB's continued to record a positive JAW (2.6%) in 6MFY18. CI ratio for HLBB improved to 42.5% for 6MFY18 vs. 43.6% in 6MFY17.
Asset quality of HLBB remained strong with a GIL ratio of 1.0% and a stable net credit cost of 0.09% in 6MFY18.
HLA Holdings, the group's insurance division, recorded a lower pre-tax profit of RM152.4mil, a decline of 19.4%YoY for 6MFY18. This was due to lower life surplus fund of RM31.9mil and a decline in share of profit from associate company of RM11.6mil.
HLA's management expense ratio remained low at 5.7% for 6MFY18.
Its Investment Banking division under Hong Leong Capital (HLC) achieved a lower PBT of RM37.4mil, (- 6.4%YoY) in 6MFY18. This was due to lower profits from its investment banking and stock broking business (- 11.1%YoY) which offset higher earnings from fund management and unit trust business (+26.7%YoY).
No dividend has been proposed in 2QFY18.
We expect the group's earnings to improve ahead. The recent increase in interest rates with BNM raising the OPR by 25bp in January 2018 will have a positive impact on the NIM of HLBB as well as earnings of HLA by lowering its provisions for contractual liabilities. Meanwhile, HLA's focus on raising its non-par/par ratio towards 70:30 from 56:44 in FY17 is expected to improve its margins for the insurance business.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....